Abstract
Heart failure (HF) is a complex syndrome, with several definitions, the commonest being “an abnormality of cardiac function whereby heart in unable to pump at a rate commensurate with the requirement of the metabolizing tissues, or does so only at elevated filling pressures”. In case of children, this requirement includes growth and development. Unlike as seen in adults, HF in children is commonly due to structural heart disease and reversible conditions. Thus the treatment for HF is commonly required for short term only. The overall outcome with HF is better in children than in adults. While the general principles on management are similar to those in adults, the evidence for the use of drugs in children is less convincing. It requires a judicious balance of extrapolation from adult medicine, keeping in mind that children are not small adults.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ramakrishnan S, Kothari SS, Bahl VK. Heart Failure-Definition and Diagnosis. Indian Heart J 2005; 57:13–20
Braunwald E, Grossman W. Clinical aspects of heart failure. In Braunwald E ed. Heart Disease: A Textbook of Cardiovascular Medicine, 4th ed. Philadelphia; Saunders, 1992; 444–463
Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary, A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2001; 104: 2996–3007
Sommers C, Nagel BH, Neudorf U, Schmaltz AA. Congestive heart failure in childhood. An epidemiologic study. Herz 2005;30:652–662.
Webster G, Zhang J, Rosenthal D. Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: a retrospective cross-sectional study. BMC Cardiovascular Disorders 2006;6: 23
Kay JD, Colan SD, Graham TP. Congestive heart failure in pediatric patients. Am Heart J 2001; 42:923–928
Lipshultz SE, Sleeper LA, Towbin JA et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003; 348:1647–1655
Towbin JA, Lowe AM, Colan SD et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA 2006;296:1867–1876
Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 2005; 95: 474–478
Ross RD, Bollinger RO, Pinsky WW. Grading the severity of congestive heart failure in infants. Pediatr Cardiol 1992; 13:72–75.
Burch M. Heart failure in the Young. Heart 2002;88:198–202
Saxena A for ’Working Group on Management of Congenital Heart Diseases in India’. Consensus on timing of intervention for common congenital heart disease. Indian Pediatr 2008;45:117–126
Keith JD, Rose V, Collins G, Kidd BS. Ventricular septal defect: incidence, morbidity, and mortality in various age groups. Br Heart J 1971; 33:81.
Saxena A, Tandon R, Shrivastava S. Clinical course of isolated ventricular sepal defect: an Indian experience. Indian J Paediatr 1993; 60:777–782
Shaddy RE, Boucek MM, Hsu DT et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA 2007;298:1171–1179
Robinson JL, Hartling L, Crumley E, Vandermeer B, Klassen TP. A systematic review of intravenous gamma globulin for therapy of acute myocarditis. BMC Cardiovasc Disord 2005;5:12
Hia CP, Yip WC, Tai BC, Quek SC. Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch Dis Child 2004;89:580–584
Canter CE, Shaddy RE, Bernstein D et al. Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement from the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;115;658–676
Duncan BW, Bohn DJ, Atz AM et al. Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J Thorac Cardiovasc Surg 2001; 122:440–448.
Stiller B, Dahnert I, Weng YG, Hennig E, Hetzer R, Lange PE. Children may survive severe myocarditis with prolonged use of biventricular assist devices. Heart 1999;82: 237–240.
Seth S, Narang R, Bhargava B, for the AIIMS Cardiovascular Stem Cell Study Group. Percutaneous intracoronary cellular cardiomyoplasty for nonischemic cardiomyopathy: clinical and histopathological results: the first-in-man ABCD (Autologous Bone Marrow Cells in Dilated Cardiomyopathy) trial. J Am Coll Cardiol 2006; 48:2350–2351
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaturvedi, V., Saxena, A. Heart failure in children: Clinical aspect and management. Indian J Pediatr 76, 195–205 (2009). https://doi.org/10.1007/s12098-009-0050-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-009-0050-0